Search

Your search keyword '"Groop PH"' showing total 554 results

Search Constraints

Start Over You searched for: Author "Groop PH" Remove constraint Author: "Groop PH"
554 results on '"Groop PH"'

Search Results

1. Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

2. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study

3. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.

8. New genetic loci link adipose and insulin biology to body fat distribution.

9. New genetic loci link adipose and insulin biology to body fat distribution

10. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

12. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.

14. Physiology and pathophysiology of GIP: a review

17. Advanced glycation end products are direct modulators of β-cell function.

19. Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study).

20. Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy.

21. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.

23. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.

26. A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes

27. Genetic studies of body mass index yield new insights for obesity biology

28. New genetic loci link adipose and insulin biology to body fat distribution

29. Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Study.

30. The role of finerenone in the management of CKD in T2D -Practical considerations for primary care.

31. Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes.

32. Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes.

33. Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.

34. Excessive occupational sitting increases risk of cardiovascular events among working individuals with type 1 diabetes in the prospective Finnish Diabetic Nephropathy Study.

35. A Novel Role for FERM Domain-Containing Protein 3 (FRMD3) in CKD.

36. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.

37. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia.

38. Increased incidence of neurodegenerative diseases in Finnish individuals with type 1 diabetes.

39. Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.

40. Adherence to cardio-protective medications and cardiovascular disease in adults with type 1 diabetes.

41. Sham-Controlled Randomized Pilot Trial on Baroreflex Activation Therapy in Resistant Hypertension.

42. Modifiable self-management practices impact nocturnal and morning glycaemia in type 1 diabetes.

43. Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S.

44. Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes.

45. Cerebral Small Vessel Disease Is Associated With Smaller Brain Volumes in Adults With Type 1 Diabetes.

46. Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes.

47. Retinal artery to vein ratio is associated with cerebral microbleeds in individuals with type 1 diabetes.

48. Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

49. Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter?

50. The use of dietary supplements, and the association between supplemental vitamin D and glycaemic control in adult individuals with type 1 diabetes.

Catalog

Books, media, physical & digital resources